Condition

Colo-rectal Cancer (dMMR/MSI-H CRC) clinical trials and research

• 2Clinical trials
• 2Countries

All recruiting trials (2)

• Tislelizumab before surgery for dMMR/MSI‑H stage II–III colorectal cancer

  This project will try giving tislelizumab before surgery to see if it helps adults with dMMR/MSI‑H stage II–III colorectal cancer.

  Recruiting Cancer Institute and Hospital, Chinese Academy of Medical Sciences · Beijing, Undefined · NCT07352280

• Subcutaneous versus intravenous immune therapy: which do patients prefer?

  This project will test whether patients with advanced cancers prefer subcutaneous (under‑the‑skin) versus intravenous nivolumab or, if available, pembrolizumab.

  Recruiting Phase 2 University of Pittsburgh · Pittsburgh, Pennsylvania · NCT07223424

Related topics

Quick answers

How many Colo-rectal Cancer (dMMR/MSI-H CRC) clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in China (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →